Evidence map›Paper›PMID 32026891›Full record

ArticleBiomaterials science2020

Labelling primary immune cells using bright blue fluorescent nanoparticles.

Maura C Belanger, Meng Zhuang, Alexander G Ball, Kristen H Richey, Christopher A DeRosa, Cassandra L Fraser, Rebecca R Pompano

Abstract read
In one paragraph

Article in Biomaterials science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maura C BelangerDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, USA. rrp2z@virginia.edu fraser@virginia.edu and Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia 22903, USA.ORCID http://orcid.org/0000-0003-2033-7631
Meng ZhuangDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, USA. rrp2z@virginia.edu fraser@virginia.edu.
Alexander G BallDepartment of Microbiology Cancer Biology and Immunology, University of Virginia, Charlottesville, Virginia 22903, USA and Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia 22903, USA.
Kristen H RicheyDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, USA. rrp2z@virginia.edu fraser@virginia.edu.
Christopher A DeRosaDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, USA. rrp2z@virginia.edu fraser@virginia.edu.
Cassandra L FraserDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, USA. rrp2z@virginia.edu fraser@virginia.edu.ORCID http://orcid.org/0000-0002-8927-4694
Rebecca R PompanoDepartment of Chemistry, University of Virginia, Charlottesville, Virginia 22904, USA. rrp2z@virginia.edu fraser@virginia.edu and Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia 22903, USA.ORCID http://orcid.org/0000-0002-8644-9313

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Thomas P. Loughran · 1987 to 2026
$72.1M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007496 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Michael G. Brown, Coleen A McNamara · 1995 to 2026
$10.2M
Modeling immunity with a hybrid lymph node tissue-chipR01AI131723 · NIAID · UNIVERSITY OF VIRGINIA · PI POMPANO, REBECCA R · 2018 to 2022
$2.3M
Luminescent Oxygen Nanosensors for Tumor Hypoxia ImagingR01CA167250 · NCI · UNIVERSITY OF VIRGINIA · PI FRASER, CASSANDRA L · 2012 to 2016
$1.7M
NCI NIH HHS P30 CA044579NCI NIH HHS R01 CA167250NIAID NIH HHS R01 AI131723NIAID NIH HHS T32 AI007496
6 · The paper itself

Abstract

Tracking cell movements is an important aspect of many biological studies. Reagents for cell tracking must not alter the biological state of the cell and must be bright enough to be visualized above background autofluorescence, a particular concern when imaging in tissue. Currently there are few reagents compatible with standard UV excitation filter sets (e.g. DAPI) that fulfill those requirements, despite the development of many dyes optimized for violet excitation (405 nm). A family of boron-based fluorescent dyes, difluoroboron β-diketonates, has previously served as bio-imaging reagents with UV excitation, offering high quantum yields and wide excitation peaks. In this study, we investigated the use of one such dye as a potential cell tracking reagent. A library of difluoroboron dibenzoylmethane (BF2dbm) conjugates were synthesized with biocompatible polymers including: poly(l-lactic acid) (PLLA), poly(ε-caprolactone) (PCL), and block copolymers with poly(ethylene glycol) (PEG). Dye-polymer conjugates were fabricated into nanoparticles, which were stable for a week at 37 °C in water and cell culture media, but quickly aggregated in saline. Nanoparticles were used to label primary splenocytes; phagocytic cell types were more effectively labelled. Labelling with nanoparticles did not affect cellular viability, nor basic immune responses. Labelled cells were more easily distinguished when imaged on a live tissue background than those labelled with a commercially available UV-excitable cytoplasmic labelling reagent. The high efficiency in terms of both fluorescence and cellular labelling may allow these nanoparticles to act as a short-term cell labelling strategy while wide excitation peaks offer utility across imaging and analysis platforms.

Indexed as

AnimalsB-LymphocytesBoron CompoundsCells, CulturedCell TrackingFemaleFluorescent DyesMaleMiceNanoparticlesPolyestersSpectrometry, FluorescenceSpleenBoron Compoundsdifluoroboron dibenzoylmethane polylactideFluorescent DyespolycaprolactonePolyesterspoly(lactide)

Identifiers

PMID32026891
PMCPMC7863618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.